Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:42 PM
Ignite Modification Date:
2025-12-24 @ 5:42 PM
NCT ID:
NCT01652768
Eligibility Criteria:
Inclusion Criteria for Caregivers (Phase I):
* are identified by the patient and/or caregiver as the "primary caregiver"
* were involved in caregiving during the first ten weeks following diagnosis at the SCC
* are capable of providing informed consent.
Exclusion Criteria for Caregivers (Phase I):
\- include those whose are caring for patients who are in hospice or within 2 months of death, as this experience may influence their recollection of the diagnosis phase of the cancer trajectory.
Inclusion Criteria for Patients (Phase II):
* are newly diagnosed malignant brain tumor patients who are at University Hospitals and who are within a week of surgery
* are receiving on-going care at the Seidman Cancer Center
* are able to identify a primary caregiver involved in their care, support, and/or care planning
* are capable of providing informed consent.
Exclusion Criteria for Patients (Phase II):
\- are those with a life expectancy of less than two months and/or those who are electing hospice care who will be receiving medical and or radiation oncology care outside of the Seidman Cancer Center.
Eligibility criteria for caregivers (Phase II)
* being identified by the patient as the "primary caregiver"
* capable of providing informed consent.
* Both the patient and caregiver must consent to be in the study.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01652768
Study Brief:
Protocol Section:
NCT01652768